Form 8-K - Current report:
SEC Accession No. 0001453687-25-000140
Filing Date
2025-12-18
Accepted
2025-12-18 16:13:02
Documents
15
Period of Report
2025-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rnac-20251216.htm   iXBRL 8-K 38256
2 EX-14.1 codeofethicsandbusinesscon.htm EX-14.1 78733
3 EX-99.1 pressreleaseofcartesianthe.htm EX-99.1 11544
7 cartesian_logoa.jpg GRAPHIC 1268513
  Complete submission text file 0001453687-25-000140.txt   1947304

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rnac-20251216.xsd EX-101.SCH 1862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rnac-20251216_lab.xml EX-101.LAB 21885
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rnac-20251216_pre.xml EX-101.PRE 12572
17 EXTRACTED XBRL INSTANCE DOCUMENT rnac-20251216_htm.xml XML 2722
Mailing Address 7495 NEW HORIZON WAY FREDERICK MD 21703
Business Address 7495 NEW HORIZON WAY FREDERICK MD 21703 301-348-8698
Cartesian Therapeutics, Inc. (Filer) CIK: 0001453687 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 251583232
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)